BioSpace News Archive

Drug Development

Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA ® (ustekinumab) in Systemic Lupus Erythematosus (SLE) due to lack of efficacy in SLE.

June 26, 2020
·
10 min read
Policy

CHMP Grants Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With KALYDECO® (ivacaftor) in People Ages 12 and Older With Cystic Fibrosis With the Most Common Genotypes

If granted Marketing Authorization, people ages 12 and older in Europe who have one F508del mutation and one minimal function mutation will for the first time be able to benefit from a medicine that treats the underlying cause of the disease

June 26, 2020
·
7 min read
Job Trends

Assure to Present at the Sidoti Virtual Microcap Conference on June 30th

Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it is scheduled to present at Sidoti’s Inaugural Microcap Virtual Conference on June 30, 2020.

June 26, 2020
·
2 min read
Resolutions of the Annual Shareholders’ Meeting of Sartorius AG - June 26, 2020

At virtual Annual General Shareholders’ Meeting, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the boards’ proposals by a large majority.

June 26, 2020
·
3 min read